Compass Therapeutics
CMPX · NASDAQ
$0.8333−$0.0017 (−0.20%)TodayMarket closed ·
Prev close $0.835
EPS: actual vs estimate
Beat the estimate in 4 of the last 8 quarters, by 19.1% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q2 FY26 | -$0.1105 | -$0.13 | −17.6% |
| Q1 FY26 | -$0.1001 | -$0.10 | +0.1% |
| Q4 FY25 | -$0.0922 | -$0.09 | +2.4% |
| Q3 FY25 | -$0.1403 | -$0.08 | +43.0% |
| Q2 FY25 | -$0.1247 | -$0.14 | −12.3% |
| Q1 FY25 | -$0.1132 | -$0.12 | −6.0% |
| Q4 FY24 | -$0.1001 | -$0.11 | −9.9% |
| Q3 FY24 | -$0.1156 | -$0.08 | +30.8% |
Earnings calls
- Goldman Sachs 47th Annual Global Healthcare Conference 2026
- Special Call - Compass Therapeutics, Inc.
- 44th Annual J.P. Morgan Healthcare Conference
- Evercore 8th Annual Healthcare Conference
- Piper Sandler 37th Annual Healthcare Conference
- Morgan Stanley 23rd Annual Global Healthcare Conference
- Special Call - Compass Therapeutics, Inc.
- Special Call - Compass Therapeutics, Inc.
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.